Clinical Trial: Real-World Treatment Patterns and Outcomes in HER2-Altered Metastatic Breast Cancer Patients in the United States

U.S., Jan. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07342309) titled 'Real-World Treatment Patterns and Outcomes in HER2-Altered Metastatic Breast Cancer Patients in the United States' on Jan. 08.

Brief Summary: This study aims to address the following key objectives in patients with HER2-altered mBC:

Primary objectives

* Estimate the prevalence of human epidermal growth factor receptor 2 positive (HER2+), human epidermal growth factor receptor 2 (HER2) mutation, cooccurrence of HER2+ and HER2 mutation among adult patients with metastatic breast cancer (mBC)

* Among mBC patients with HER2+ and HER2 mutation, describe the following:

* Baseline demographic and clinical characteristics

* Treatment p...